Form 8-K - Current report:
SEC Accession No. 0001193125-26-304984
Filing Date
2026-07-16
Accepted
2026-07-15 17:36:30
Documents
13
Period of Report
2026-07-15
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d159184d8k.htm   iXBRL 8-K 44506
2 EX-3.1 d159184dex31.htm EX-3.1 8147
3 EX-3.2 d159184dex32.htm EX-3.2 111041
  Complete submission text file 0001193125-26-304984.txt   312929

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cprx-20260715.xsd EX-101.SCH 3198
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20260715_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20260715_pre.xml EX-101.PRE 11719
17 EXTRACTED XBRL INSTANCE DOCUMENT d159184d8k_htm.xml XML 3892
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 261178188
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)